Facebook Linkedin RSS Twitter Youtube
Home 2024

Nucleic acid therapeutics

Using Oxford Nanopore’s Multi-Omic Sequencing to Optimize Plasmids and Vectors for Cell and Gene Therapies
Drug Discovery

Using Oxford Nanopore’s Multi-Omic Sequencing to Optimize Plasmids and Vectors for Cell and Gene Therapies

Neurodevelopmental Role for lncRNA Confirmed in Humans, May Influence Autism, Epilepsy
Genome Editing

Neurodevelopmental Role for lncRNA Confirmed in Humans, May Influence Autism, Epilepsy

Focusing on Structural Changes May Be Key to AAV Separation
Bioprocessing

Focusing on Structural Changes May Be Key to AAV Separation

StockWatch: Wave’s RNA Editing Milestone Lifts Korro, ProQR
GEN Edge

StockWatch: Wave’s RNA Editing Milestone Lifts Korro, ProQR

Wave Clinical Trial Shows First Successful RNA Editing in Humans
Genome Editing

Wave Clinical Trial Shows First Successful RNA Editing in Humans

Aptadir Therapeutics Pioneers RNA Inhibitors That Target Hypermethylation in Rare Genetic Disorders
Cancer

Aptadir Therapeutics Pioneers RNA Inhibitors That Target Hypermethylation in Rare Genetic Disorders

RNA Therapeutic Development
New Products

RNA Therapeutic Development

Animal Models Aren’t Human!
Drug Discovery

Animal Models Aren’t Human!

Electroporation in Cell Therapy
Artificial Intelligence

Electroporation in Cell Therapy

Keys for Sustained mRNA Sector Growth
Bioprocessing

Keys for Sustained mRNA Sector Growth

123...52Page 2 of 52
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.